Company intelligence / Profile preview

Power Leaves

Ownership: Private
Development stage: Commercial

Overview

Power Leaves has completed initial exports of proprietary decocainized coca leaf extract and essence for product testing in food, nutraceuticals, and cosmetics. The company has begun developing protocols to clinically validate health claims related to energy enhancement and appetite suppression but has not yet reported clinical results.

Industry: Food & Nutrition

Drug pipeline

1 asset

Coca X

Commercial

Partnerships

Eurofins NSC Canada Inc. (for product testing/formulation)Intertek (for scientific validation of health claims)

Beyond the preview

Go deeper on Power Leaves.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Power Leaves.

Explore the full profile